Bruyère Health is proud to stand among the hospitals, universities, and colleges in the region, highlighting the strength of Ottawa’s health and life science research environment.
Load More
A coalition of Canada's top dementia experts will test the Foresight™ platform by Canadian-based Perceiv Research Inc.
National Art Exhibition Inspires Canadian Artists to Reimagine the End of Life
Health Canada has now approved the use of lecanemab for treating early-stage Alzheimer’s disease.
Bruyère Health is creating a Master Retail Strategy that will help revamp retail and food services across all our sites.
Four knowledge brokers share how collaboration is at the heart of evidence-based care
Earlier this year, we launched a pilot project at our Market Site using Friendlier, a reusable food container program.
September 17 marks Rehabilitation Day, a celebration of the critical role of rehabilitation in recovery and quality of life, and the dedicated teams that make this possible.
An international team of researchers has received $1 million to launch one of the largest multinational studies to date examining how cardiovascular health influences the risk of Alzheimer’s disease and related dementias.